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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. 
1. Health Evidence Summary 
The Global impact of COVID-19 and strategies for mitigation and 
suppression 
Walker, PGT, Whittaker, C et al. | WHO Collaborating Centre for Infectious Disease 
Modelling, MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute 
for Disease and Emergency Analytics, Imperial College London | 26 March 2020 | Report 12 
https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-
fellowships/Imperial-College-COVID19-Global-Impact-26-03-2020.pdf 
In the absence of interventions, this study estimates that COVID-19 would have resulted in 
7.0 billion infections and 40 million deaths globally this year. Considering mitigation scenarios, 
social distancing to reduce the rate of social contacts by 40% and with a 60% reduction in the 
elderly population at highest risk could reduce this burden by approximately half. However, 
even at this level, health systems in all countries would be rapidly overwhelmed where “peak 
demand for critical care beds in a typical low-income setting outstripping supply by a factor of 
25, in contrast to a typical high-income setting where this factor is 7”. Healthcare demand can 
only be kept within manageable levels through rapid implementation of public health measures 
to suppress transmission. Early implementation of a suppression strategy (at 0.2 deaths per 
100,000 population per week) – including testing and isolation of cases and wider social 
distancing to prevent onward transmission - could avert 95% of deaths saving 38.7 million 
lives. Adopted later (at 1.6 deaths per 100,000 population per week) 30.7 million lives could 
be saved. Individual country outputs are now being shared to enable figures to guide planning. 
Note model outputs are not predictions of what will happen but rather to illustrate the 
magnitude of the problem and benefits of rapid, decisive and collective action. Wider social 
and economic costs of suppression are not considered in this analysis but are likely to be high 
and disproportionately so in lower income settings. 
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The effect of control strategies to reduce social mixing on 
outcomes of the COVID-19 epidemic in Wuhan, China: a modelling 
study 
Prem, K, Liu Y et al. | The Lancet Public Health | 25 March 2020 | Article 
https://doi.org/10.1016/S2468-2667(20)30073-6 
Estimates of the effects of physical distancing measures on the progression of the COVID-19 
epidemic in Wuhan, China found that changes to contact patterns are likely to have 
substantially delayed the epidemic peak and reduced the number of COVID-19 cases here. 
Projections suggest that premature and sudden lifting of interventions (in March 2020) could 
lead to an earlier second peak in late August 2020, which could be delayed by 2 months to 
October and the height of the peak reduced if restrictions are relaxed a month later, in April 
2020. This would also buy time for health systems to respond and expand. The authors hope 
these results provide some insights for policymakers in the rest of the world but do highlight 
the limitations to their analysis, including large uncertainties around estimates of R0 and the 
duration of infectiousness.  
 
COVID-19: extending or relaxing distancing control measures 
Colbourn T | The Lancet Public Health | 25 March 2020 | Comment 
https://doi.org/10.1016/S2468-2667(20)30072-4 
This Comment discusses the study by Prem and colleagues (above) – an additional month of 
physical distancing measures (or other methods, such as widespread testing) would provide 
2 additional months before such measures would need to be reinstated to prevent health 
system overload. Note the potential epidemic resurgence reflects that shown in the model 
developed by Ferguson and colleagues. Safe ways out of lockdown need to be identified given 
that many countries with increasing epidemics now potentially face their first lockdown. 
Country-specific modelling should compare lockdown measures to the main alternative – 
testing, contact tracing, and localised quarantine of suspected cases at either the start of the 
epidemic or after relaxation of lockdown measures. Such modelling would guide when 
lockdown measures could be relaxed i.e. at what proportion of the population tested (and how 
regularly given asymptomatic and pre-symptomatic transmission) would there be confidence 
that the epidemic is being sufficiently controlled to considerably delay or even prevent 
resurgence. Emerging data from South Korea, which adopted an early widespread testing 
strategy and has so far avoided the need for widespread lockdown, and Italy, now attempting 
this strategy as a way out of lockdown, will prove useful. As more data become available on 
the transmissibility of this novel coronavirus, models can more accurately predict the success 
or failure of different strategies to control the epidemic and limit mortality.  
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Clinical and epidemiological features of 36 children with 
coronavirus disease 2019 (COVID-19) in Zhejiang China: an 
observational cohort study 
Qiu H., Wu, J. et al | The Lancet | 25 March 2020 | Article 
https://doi.org/10.1016/S1473-3099(20)30198-5 
Between 17 Jan and 1 March 2020, only 36 of 661 cases of COVID-19 reported in Ningbo and 
Wenzhou, Zhejiang province, China were in children. All 36 had been infected either by close 
contact with adults infected with SARS-CoV-2 or by exposure to the epidemic area. Nearly 
half were asymptomatic (i.e. no fever or no cough) and where symptoms presented, they were 
milder than in adults. Given the large proportion of asymptomatic children, identifying them in 
the absence of clear epidemiological information presents a challenge in preventing 
community-acquired infection.   
 
Fundamental principles of epidemic spread highlight the immediate 
need for large-scale serological surveys to assess the stage of the 
SARS-COV-2 epidemic 
Lourenco J, Paton R, Ghafari M, et al. | University of Oxford | Unpublished draft COVID-19 
model 
https://www.dropbox.com/s/oxmu2rwsnhi9j9c/Draft-COVID-19- Model%20%2813%29.pdf 
Note: includes a disclaimer that “(a) material is not final and is subject to be updated any 
time and (b) Code used will be made available as soon as possible. 
This susceptible-infected-recovered model suggests that half the UK population might 
already have been infected with COVID-19.  
 
Covid-19: experts question analysis suggesting half UK population 
has been infected 
Sayburn A. | BMJ | 25 March 2020 | News 
https://doi.org/10.1136/bmj.m1216 
If the University of Oxford hypothesis that large numbers of the UK population have already 
been infected but remain asymptomatic proves correct, this would not change the current 
public health advice to reduce the spread of the virus in the UK but would change long term 
expectations. 
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Tackling two pandemics: a plea on World Tuberculosis Day 
Wingfield at al. | The Lancet Respiratory Medicine | 24 March 2020 | Comment 
https://doi.org/10.1016/S2213-2600(20)30151-X 
Reflecting on the similarities, differences and unknowns of the TB and COVID-19 pandemics 
and a plea to not forget the TB pandemic. 
 
COVID-19 in Europe: the Italian lesson 
Saglietto et al. | The Lancet | 24 March 2020 | Correspondence 
https://doi.org/10.1016/S0140-6736(20)30690-5 
Projections from data trends before 8 March predicted more than 30,000 cases by 15 March 
2020. A recorded number of 24,747 cases by 15 March 2020, suggests that measures 
introduced by 11 March 2020 began reducing the number of new cases within 3 to 4 days. 
Authors urge all countries to “acknowledge the Italian lesson” and immediately adopt very 
restrictive measures to limit virus spread, ensure appropriate health system response, and 
reduce mortality. Includes a figure of epidemic curves for European countries, with estimated 
lag time from Italy’s situation, as of 15 March 2020 (source: Center for Systems Science and 
Engineering, Johns Hopkins University).  
 
Sex, gender and COVID-19: Disaggregated data and health 
disparities 
Purdie et al. | BMJ GH Blogs | 24 March 2020 | Blog 
https://blogs.bmj.com/bmjgh/2020/03/24/sex-gender-and-covid-19-disaggregated-data-and-
health-disparities/ 
Male sex was associated with worse clinical outcomes due to SARS in Hong Kong, and a 
higher risk of dying from MERS. Not all countries, including the UK, are yet publishing data 
(cases and deaths) disaggregated by sex. This is important to determine if sex and gender, 
along with age, influence acquisition, transmission and health outcomes associated with 
COVID-19 which would guide clinical care. Data from countries that have reported confirmed 
cases by sex (13 countries) show a mixed picture but data show a higher proportion of deaths 
in men than women (ranging from 9% to 89% higher in men than women) in four out of six 
countries that report mortality by sex. Risky behaviours consistently found to be more common 
among men than women worldwide e.g. rates of smoking tobacco are higher in men than 
women. These behaviours are associated with both the risk of developing co-morbidities now 
found to be associated with adverse outcomes in COVID-19, and with behaviours that are 
intimately bound up with gender norms. 
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2. Tracking COVID-19 cases 
Global 
WHO COVID-19 daily situation reports 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports 
An interactive web-based dashboard to track COVID-19 in real time 
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd4029942
3467b48e9ecf6 
Live data tracker: sex-disaggregated COVID-19 data from the 25 most-affected countries 
http://globalhealth5050.org/covid19 
Africa 
Africa Centres for Disease Control and Prevention (Africa CDC) 
http://www.africacdc.org/covid-19-and-resources 
Coronavirus in Africa Tracker: How many covid-19 cases & where? 
https://africanarguments.org/2020/03/23/coronavirus-in-africa-tracker-how-many-cases-and-
where-latest/ 
South African Government COVID-19 
https://www.gov.za/Coronavirus 
UK 
COVID-19: PHE track coronavirus cases in the UK 
https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases 
UK case tracing infographic 
https://www.arcgis.com/apps/opsdashboard/index.html#/f94c3c90da5b4e9f9a0b19484dd4b
b14 
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3. Online course 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 23 March 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
A reminder that this course is currently running. On this course you will learn what is known 
about the outbreak of COVID-19 (week 1); what the practical implications for responding to 
COVID-19 are (week 2); and what we need to find out about COVID-19 (week 3). 
4. Resource Hubs 
NICE UK: Rapid guidelines and evidence reviews  
https://www.nice.org.uk/covid-19 
Imperial College London MRC Centre for Global Infectious Disease Analysis COVID-19 
reports 
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ 
Global research on COVID-19 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-
novel-coronavirus-2019-ncov 
WHO R&D Blueprint 
https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/ 
WHO: Coronavirus disease (COVID-19) outbreak resources 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 
Latest information and advice from the UK Government 
https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public 
CDC COVID-19 Resources 
https://www.cdc.gov/coronavirus/2019-ncov/index.html 
The Lancet COVID-19 Resource Centre 
https://www.thelancet.com/coronavirus 
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Elsevier’s Novel Coronavirus Information Center 
https://www.elsevier.com/connect/coronavirus-information-center 
Cell Press Coronavirus Resource Hub 
https://www.cell.com/2019-nCOV 
Cochrane Special Collections - COVID-19: infection control and prevention measures 
https://www.cochranelibrary.com/collections/doi/SC000040/full 
The BMJ Coronavirus (covid-19): Latest news and resources 
https://www.bmj.com/coronavirus?int_source=wisepops&int_medium=wisepops&int_campai
gn=DAA_CoronaVirus_Jan24 
Johns Hopkins Coronavirus Resource Centre 
https://coronavirus.jhu.edu 
Global Partnership for Sustainable Development – COVID-19 resources 
http://www.data4sdgs.org/resources/covid-19-resources 
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